Lazuriton Nano Biotechnology (U.S.A.) Inc.: key financial figures for fiscal year 2021 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2021): $0
Net Income/Loss (FY2021): -$48.8K
Total Assets (FY2021): $1.3K
Total Equity (FY2021): -$368.6K
Cash Flows from Operating Activities (FY2021): $0

Source: Lazuriton Nano Biotechnology (U.S.A.) Inc. 10-K filing (FY2021). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.

Lazuriton Nano Biotechnology (U.S.A.) Inc.: key financial figures for fiscal year 2021 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2021): $0
Net Income/Loss (FY2021): -$48.8K
Total Assets (FY2021): $1.3K
Total Equity (FY2021): -$368.6K
Cash Flows from Operating Activities (FY2021): $0

Source: Lazuriton Nano Biotechnology (U.S.A.) Inc. 10-K filing (FY2021). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.